A collaborative study led by researchers in Arizona found that a new blood test improves early detection of Alzheimer's ...

A Columbia University study suggests that combining p-tau217 blood tests with APOE4 genetic testing may help predict the onset of Alzheimer's disease symptoms.

A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive ...

Along with knowing more about Alzheimer’s disease, public education needs to openly address the option of not having to live ...

Jeremy Scott told Newsweek he remembers having a strange experience at a Disney resort years before his diagnosis.

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...

The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-β (Aβ). Using the APPPS1 ...

Alzheimer’s R&D is shifting toward disease modification, with amyloid, tau, RNA and immune targets driving trials, partnerships and oral therapy opportunities.Dublin, Sept. (GLOBE NEWSWIRE) -- ...

The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.

A new proprietary analysis of cutting-edge Alzheimer's drugs finds growing excitement around experimental therapies targeting ...

Social media posts about blood tests meant to aid in the diagnosis of Alzheimer’s disease often leave out critical ...

People in the Minot community walked Sunday to raise awareness and money for a cure for Alzheimer’s disease.